Madivalappa Davanagere Prabhakara, Maiti Barnali
Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore 632014, India.
ACS Omega. 2021 Oct 1;6(40):26035-26047. doi: 10.1021/acsomega.1c02976. eCollection 2021 Oct 12.
A simple and novel methodology has been developed for the synthesis of 1,3-bis(carboxymethyl)imidazolium chloride [BCMIM][Cl] salt. The ionic salt [BCMIM][Cl] catalyzed the reaction among arylaldehydes; the substituted 1,3-dicarbonyl compounds and urea/thiourea at 80 °C with 5 mol % under neat condition provided the substituted dihydropyrimidin-2(1)-one/thiones in the synthesis step with yields of up to 96%. In addition, we synthesized the commercially available drug Monastrol by employing this methodology. The new synthesis method employs the benefits of a broad substrate scope, short reaction time, and high atom economy along with low catalyst loading in neat conditions, and is devoid of chromatographic purification. The ionic salt [BCMIM][Cl] was recycled and reused up to six cycles without substantial damage of its catalytic efficiency.
已开发出一种简单新颖的方法来合成1,3 - 双(羧甲基)咪唑鎓氯化物[BCMIM][Cl]盐。离子盐[BCMIM][Cl]催化芳醛之间的反应;在80℃、5 mol%、无溶剂条件下,取代的1,3 - 二羰基化合物与尿素/硫脲反应,在合成步骤中得到取代的二氢嘧啶 - 2(1) - 酮/硫酮,产率高达96%。此外,我们采用这种方法合成了市售药物莫那可尔。这种新的合成方法具有底物范围广、反应时间短、原子经济性高以及在无溶剂条件下催化剂负载量低的优点,且无需色谱纯化。离子盐[BCMIM][Cl]可循环使用多达六个循环,其催化效率无明显损失。